Buemi M - Search Results

1

Rapid and transient lymphocytopenia after i.v. administration of high doses of human recombinant erythropoietin.

Buemi M, Allegra A, Corica F, Cavallaro G, Aloisi C, Pettinato G, Frisina N. Buemi M, et al. Hematopathol Mol Hematol. 1997-1998;11(1):13-7. Hematopathol Mol Hematol. 1997. PMID: 9439976

2

Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia.

Buemi M, Aloisi C, Cavallaro E, Corica F, Floccari F, Grasso G, Lasco A, Pettinato G, Ruello A, Sturiale A, Frisina N. Buemi M, et al. J Nephrol. 2002 Mar-Apr;15(2):97-103. J Nephrol. 2002. PMID: 12018644 Review.

3

Influence of therapy with recombinant erythropoietin on serum levels of neopterin in hemodialyzed subjects.

Buemi M, Allegra A, Aloisi C, Frisina N. Buemi M, et al. Am J Nephrol. 1991;11(4):281-3. doi: 10.1159/000168322. Am J Nephrol. 1991. PMID: 1799185

4

Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients.

Buemi M, Allegra A, Laganà A, Aloisi C, Privitera M, Morabito N, Frisina N. Buemi M, et al. Riv Eur Sci Med Farmacol. 1993 Sep-Dec;15(5-6):195-7. Riv Eur Sci Med Farmacol. 1993. PMID: 7761669 Clinical Trial.

5

Effects of intravenous administration of recombinant human erythropoietin in rats subject to hemorrhagic shock.

Buemi M, Allegra A, Squadrito F, Buemi AL, Laganà A, Aloisi C, Frisina N. Buemi M, et al. Among authors: buemi al. Nephron. 1993;65(3):440-3. doi: 10.1159/000187526. Nephron. 1993. PMID: 8289996

6

Recombinant human erythropoietin inhibits the cutaneous vasodilatation induced by acetylcholine.

Buemi M, Denuzzo G, Allegra A, Aloisi C, Squadrito F, Squadrito G, Dattola A, Corica F, Vermiglio G. Buemi M, et al. Int J Microcirc Clin Exp. 1995 Nov-Dec;15(6):283-6. doi: 10.1159/000179076. Int J Microcirc Clin Exp. 1995. PMID: 8721436

7

[Rapid, progressive deterioration of renal function following erroneous administration of high doses of subcutaneous recombinant erythropoietin].

Buemi M, Allegra A, Aloisi C, Corica F, Frisina N. Buemi M, et al. Riv Eur Sci Med Farmacol. 1996 Jan-Feb;18(1):39-42. Riv Eur Sci Med Farmacol. 1996. PMID: 8766781 Italian.

8

Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration.

Buemi M, Allegra A, Corica F, Floccari F, D'Avella D, Aloisi C, Calapai G, Iacopino G, Frisina N. Buemi M, et al. Nephrol Dial Transplant. 2000 Mar;15(3):422-3. doi: 10.1093/ndt/15.3.422. Nephrol Dial Transplant. 2000. PMID: 10692533 Free article. No abstract available.

9

In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage.

Buemi M, Grasso G, Corica F, Calapai G, Salpietro FM, Casuscelli T, Sfacteria A, Aloisi C, Alafaci C, Sturiale A, Frisina N, Tomasello F. Buemi M, et al. Eur J Pharmacol. 2000 Mar 24;392(1-2):31-4. doi: 10.1016/s0014-2999(00)00081-9. Eur J Pharmacol. 2000. PMID: 10748269

10

Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps.

Buemi M, Vaccaro M, Sturiale A, Galeano MR, Sansotta C, Cavallari V, Floccari F, D'Amico D, Torre V, Calapai G, Frisina N, Guarneri F, Vermiglio G. Buemi M, et al. Acta Derm Venereol. 2002;82(6):411-7. doi: 10.1080/000155502762064520. Acta Derm Venereol. 2002. PMID: 12575845 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters